Man Group
AGIO icon

Man Group’s Agios Pharmaceuticals AGIO Stock Holding History

Man Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.62M Sell
124,466
-19,831
-14% -$602K 0.01% 1179
2026
Q1 		$4.88M Buy
+144,297
New +$4.09M 0.01% 1172
2025
Q2 		– Sell
-11,622
Closed -$341K – 2155
2025
Q1 		$341K Buy
+11,622
New +$386K ﹤0.01% 1903
2024
Q1 		– Sell
-180,428
Closed -$4.02M – 2103
2023
Q4 		$4.02M Buy
+180,428
New +$4.04M 0.01% 1041
2023
Q3 		– Sell
-170,631
Closed -$4.51M – 959
2023
Q2 		$4.83M Buy
+170,631
New +$4.25M 0.01% 886
2023
Q1 		– Sell
-98,700
Closed -$2.62M – 992
2022
Q4 		$2.77M Buy
98,700
+35,900
+57% +$1.01M 0.01% 1041
2022
Q3 		$1.78M Buy
+62,800
New +$1.68M 0.01% 1106
2022
Q2 		– Hold
0
– – – 1194
2021
Q4 		– Sell
-10,169
Closed -$469K – 1932
2021
Q3 		$469K Sell
10,169
-30,946
-75% -$1.5M ﹤0.01% 1549
2021
Q2 		$2.27M Sell
41,115
-150,564
-79% -$8.42M 0.01% 1191
2021
Q1 		$9.9M Sell
191,679
-159,272
-45% -$7.89M 0.04% 435
2020
Q4 		$15.2M Sell
350,951
-8,974
-2% -$355K 0.07% 293
2020
Q3 		$12.6M Buy
359,925
+241,590
+204% +$10.6M 0.05% 397
2020
Q2 		$6.33M Buy
118,335
+112,495
+1,926% +$5.21M 0.03% 563
2020
Q1 		$207K Sell
5,840
-1,225
-17% -$56.6K ﹤0.01% 1462
2019
Q4 		$337K Sell
7,065
-21,954
-76% -$830K ﹤0.01% 1650
2019
Q3 		$940K Buy
29,019
+7,184
+33% +$297K ﹤0.01% 1449
2019
Q2 		$1.09M Sell
21,835
-3,858
-15% -$206K ﹤0.01% 1501
2019
Q1 		$1.73M Sell
25,693
-8,664
-25% -$505K 0.01% 1394
2018
Q4 		$1.58M Buy
34,357
+16,640
+94% +$1.03M 0.01% 1299
2018
Q3 		$1.37M Buy
17,717
+6,877
+63% +$553K 0.01% 1543
2018
Q2 		$913K Sell
10,840
-4,160
-28% -$363K ﹤0.01% 1629
2018
Q1 		$1.23M Buy
+15,000
New +$1.16M 0.01% 1451

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Man Group's AGIO Position: Q2 2026 in Review

Man Group reduced its Agios Pharmaceuticals (AGIO) stake by 14% in Q2 2026, selling an estimated $602K and leaving 124,466 shares worth $4.62M. The position accounts for 0.01% of the portfolio, ranked #1179.

Man Group first reported a position in AGIO in Q1 2018 and has held it in 22 quarters since. The position peaked at $15.2M in Q4 2020. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Man Group held 124,466 shares of Agios Pharmaceuticals worth $4.62M as of Q2 2026.
  • Man Group sold 19,831 Agios Pharmaceuticals shares in Q2 2026, an estimated $602K.
  • Agios Pharmaceuticals made up 0.01% of Man Group's portfolio in Q2 2026, its #1179 holding.
  • Man Group first reported a position in Agios Pharmaceuticals in Q1 2018 and has held it in 22 quarters since.
  • Man Group's Agios Pharmaceuticals position peaked at $15.2M in Q4 2020.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.